Strength
.5 mg/mL
Manufacturer
Cipla USA Inc.NDC
69097034135
Classification
Generic
Dosage Form
EMULSION
Route
OPHTHALMIC
Last Updated
2/18/2026
Active Ingredients
DIFLUPREDNATEApproval Type
Generic (ANDA)
FDA Application
ANDA211776On Market Since
8/9/2021
Related Drugs
Same classification
No related drugs found.